GENETIC SCREENING OF WORKERS
United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight
Washington, DC: U.S. Government Printing Office [GPO], 1982. 128 p.
Showing items related by title, author, creator and subject.
DIRECT-TO-CONSUMER GENETIC TESTS: MISLEADING TEST RESULTS ARE FURTHER COMPLICATED BY DECEPTIVE MARKETING AND OTHER QUESTIONABLE PRACTICES: TESTIMONY BEFORE THE SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS, COMMITTEE ON ENERGY AND COMMERCE, HOUSE OF REPRESENTATIVES United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations [and] United States. Government Accountability Office (2010)
Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs Letter From William J. Scanlon, Director, Health Financing and Public Health Issues to Rep. Thomas Bliley, Jr. and Rep. John D. Dingell on the U.S. Congress, House, Committee on Commerce and Rep. Fred Upton and Rep. Ron Klink on the U.S. Congress, House, Committee on Commerce, Subcommittee on Oversight and Investigations Scanlon, William J. (United States. General Accounting Office [GAO]. Health, Education and Human Services Division, 1999-02-26)
Possible Health Effects of Pyridostigmine Bromide of Persian Gulf War Veterans. Joint Hearing Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs. U.S. House Of Representatives, 106th Congress, 1st Session. November 16, 1999. 138 P Unknown creator (United States. Congress. House of Representatives. Committee on Veterans' Affairs. Subcommittee on HealthSubcommittee on Oversight and Investigations, 2000)